机器人与同期胸腔镜肺癌手术治疗费用的比较

Cost of robotic versus thoracoscopic lung cancer surgery:A retrospective study

目的:比较机器人与胸腔镜肺癌手术的治疗费用差异。方法:回顾性收集2019年11月—2022年4月于武汉大学中南医院接受机器人和胸腔镜肺癌手术的581例患者的临床资料。将患者分为机器人组(188例)和胸腔镜组(393例),比较两组患者基线特征,并分析两组患者的治疗费用差异。结果:两组患者基线特征整体一致。机器人手术术中出血量显著低于胸腔镜手术组(P<0.05)。机器人组医疗费用显著高于胸腔镜组(P<0.05),主要差异在于机器人使用费用(手术费用和耗材费用)(P<0.05)。手术并发症、术后引流时间、术后住院时间两组间差异没有统计学意义(P>0.05)。结论:机器人与胸腔镜肺手术总费用的主要差异在于机器人使用费用,机器人手术在控制术中出血量方面更具有优势。

Objective:To compare the treatment cost difference between robotic and thoracoscopic lung cancer surgery.Methods:Clinical data of 581 patients who underwent robotic and thoracoscopic lung cancer surgery in Zhongnan Hospital of Wuhan University from November 2019 to April 2022 were retrospectively collected.The patients were divided into a robotic group(n=188)and a thoracoscopic group(n=393).The baseline characteristics were compared between the two groups,and differences in treatment costs were analyzed.Results:The baseline characteristics were generally consistent between the two groups.Intraoperative blood loss was significantly lower in the robotic surgery group than in the thoracoscopic surgery group(P<0.05).Medical costs in the robotic group were significantly higher than those in the thoracoscopy group(P<0.05),and the main differences were in the cost of robotic usage(surgical cost and consumables)(P<0.05).There were no differences in surgical com‐plications,postoperative drainage time,or postoperative hospital stay between the two groups(P>0.05).Conclusion:The main difference in the total cost of robotic versus thoracoscopic pulmonary surgery is derived from the cost of robotic usage.Robotic surgery offers advantages in controlling intraoperative blood loss.